~ The Global Biobusiness Forum

Monthly Archives: October 2013

BioAsia 2014 brings together Science-to-Business bridges for the biotechnology industry, for driving innovation in biotech industry through its “Technology Tracks” and to help you put technology in the development relay across the world through co-development opportunities & to build capabilities to break resistors for smooth flow of technology and collaborations.
Visit www.2014.bioasia.in for more details.

BioAsia 2013 saw participation of Spain as a “Country Partner” wherein a delegation of Spanish Industries & Institutes was witnessed. In a special address, Ms Carmen Vela Olmo, Minister of State – Research, Development & Innovation – fromGovernment of Spain said “For Spain, participating in this well established forum focusing on biotechnology has been considered a priority in order to give continuity to our joint bilateral efforts with our Indian counterparts. The Spanish delegation comprising of leading research institutes, companies and technology centers has firm interest in India at the forefront in diverse fields of biotechnology and its applications and we are confident that BioAsia will offer a great networking platform to all the participants.

BioAsia 2014 to witness participation of over 50 countries. Visitwww.2014.bioasia.in for more details.

Dr. Freda C. Lewis-Hall, M.D, FAPA has been the Chief Medical Office of Pfizer Inc. since May 2009 and has been an Executive Vice President since December 2010. Dr. Lewis-Hall has extensive leadership experience across multiple functional areas in the pharmaceutical industry.

BioAsia 2014 brings together Science-to-Business bridges for the biotechnology industry, for driving innovation in biotech industry through its “Technology Tracks” and to help you put technology in the development relay across the world through co-development opportunities &amp; to build capabilities to break resistors for smooth flow of technology and collaborations.